Aeon Co.(M) Target Price Raised to MYR1.95 From MYR1.86 by Maybank IB >6599.KU
AEON Biopharma Analyst Ratings
HC Wainwright & Co. Reiterates Buy on AEON Biopharma, Maintains $5 Price Target
Buy Rating on AEON Biopharma: Strategic FDA Alignment and Positive Long-Term Revenue Projections
AEON Thana Sinsap (Thailand) Target Price Raised to THB150.00 From THB148.00 by UOB Kay Hian >AEONTS.TH
AEON Biopharma Analyst Ratings
HC Wainwright & Co. Maintains Buy on AEON Biopharma, Lowers Price Target to $5
AEON Biopharma Analyst Ratings
Buy Rating Affirmed for AEON Biopharma on Strategic Biosimilar Pathway and Promising Phase 3 Study Prospects
AEON Biopharma Analyst Ratings
Buy Rating Affirmed for AEON Biopharma: Strategic Cost-Cutting and ABP-450's Broad Market Potential
AEON Biopharma Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: AEON Biopharma (AEON), Palatin Technologies (PTN)
AEON Biopharma Analyst Ratings
HC Wainwright & Co. Reiterates Buy on AEON Biopharma, Maintains $18 Price Target
AEON Biopharma Analyst Ratings
Analysts Have Conflicting Sentiments on These NA Companies: Digital Realty (DLR) and AEON Biopharma (AEON)
AEON Biopharma Analyst Ratings
H.C. Wainwright Initiates a Buy Rating on AEON Biopharma (AEON)
No Data
No Data